Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune complexome analysis of serum samples from non-small-cell lung cancer patients identifies predictive biomarkers for nivolumab therapy.
Aizawa R, Nakamura Y, Ikeda T, Aibara N, Kutsuna YJ, Kurosaki T, Aki K, Junya H, Nakagawa H, Sato K, Kodama Y, Nakashima MN, Nakashima M, Mukae H, Ohyama K. Aizawa R, et al. Among authors: nakamura y. Clin Chim Acta. 2022 Jul 1;532:84-88. doi: 10.1016/j.cca.2022.05.021. Epub 2022 Jun 3. Clin Chim Acta. 2022. PMID: 35667476
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
Tomonaga N, Nakamura Y, Soda H, Nagashima S, Nakano H, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Soejima Y, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Tomonaga N, et al. Among authors: nakamura y. Cancer Chemother Pharmacol. 2008 Jun;62(1):43-9. doi: 10.1007/s00280-007-0571-z. Epub 2007 Aug 24. Cancer Chemother Pharmacol. 2008. PMID: 17717667 Clinical Trial.
[Two cases of pleomorphic carcinoma with severe systemic inflammation].
Yoda A, Nakayama S, Abe K, Inoue K, Nakamura Y, Tagawa T, Hayashi T, Mukae H, Kohno S, Ozono Y. Yoda A, et al. Among authors: nakamura y. Nihon Kokyuki Gakkai Zasshi. 2009 Aug;47(8):751-7. Nihon Kokyuki Gakkai Zasshi. 2009. PMID: 19764522 Review. Japanese.
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
Yamaguchi H, Soda H, Nakamura Y, Takasu M, Tomonaga N, Nakano H, Doi S, Nakatomi K, Nagashima S, Takatani H, Fukuda M, Hayashi T, Tsukamoto K, Kohno S. Yamaguchi H, et al. Among authors: nakamura y. Cancer Chemother Pharmacol. 2011 Feb;67(2):331-8. doi: 10.1007/s00280-010-1325-x. Epub 2010 Apr 17. Cancer Chemother Pharmacol. 2011. PMID: 20401612 Clinical Trial.
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.
Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S. Nakamura Y, et al. J Thorac Oncol. 2011 Jan;6(1):121-7. doi: 10.1097/JTO.0b013e318200e4e8. J Thorac Oncol. 2011. PMID: 21150467 Free article. Clinical Trial.
14,272 results
You have reached the last available page of results. Please see the User Guide for more information.